Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience.
Héloïse BourienXavier PalardYan RollandFanny Le DuLuc BeuzitThomas UguenSamuel Le SourdMarc PrachtVincent ManceauAstrid LièvreKarim BoudjemaEtienne GarinJulien EdelinePublished in: European journal of nuclear medicine and molecular imaging (2018)
Our results confirm that RE is a promising treatment modality in BTC. A high proportion of patients could be downstaged to surgery, with promising long-term survival. Dose delivered to the tumor correlated with clinical outcomes when chemotherapy was not used concomitantly.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- minimally invasive
- prognostic factors
- coronary artery bypass
- squamous cell carcinoma
- radiation therapy
- high resolution
- atrial fibrillation
- coronary artery disease
- acute coronary syndrome
- mass spectrometry
- combination therapy
- liver metastases
- smoking cessation